Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
Daiichi Sankyo
Deloitte
Express Scripts
Johnson and Johnson
Fuji

Generated: April 19, 2019

DrugPatentWatch Database Preview

Ajanta Pharma Ltd Company Profile

« Back to Dashboard

What is the competitive landscape for AJANTA PHARMA LTD, and what generic and branded alternatives to AJANTA PHARMA LTD drugs are available?

AJANTA PHARMA LTD has twenty-nine approved drugs.

There is one tentative approval on AJANTA PHARMA LTD drugs.

Summary for Ajanta Pharma Ltd
US Patents:0
Tradenames:24
Ingredients:23
NDAs:29
Drug Master File Entries: 2

Drugs and US Patents for Ajanta Pharma Ltd

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ajanta Pharma Ltd DOXYCYCLINE HYCLATE doxycycline hyclate CAPSULE;ORAL 211012-002 Sep 24, 2018 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Ajanta Pharma Ltd ARIPIPRAZOLE aripiprazole TABLET;ORAL 206174-003 Sep 12, 2016 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Ajanta Pharma Ltd SILDENAFIL CITRATE sildenafil citrate TABLET;ORAL 210394-001 May 4, 2018 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Ajanta Pharma Ltd ARIPIPRAZOLE aripiprazole TABLET;ORAL 206174-005 Sep 12, 2016 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Ajanta Pharma Ltd FENOFIBRATE fenofibrate TABLET;ORAL 210138-002 Jul 23, 2018 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

Subscribe to access the full database, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Teva
UBS
US Army
Deloitte
Harvard Business School
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.